Profile
International Journal of Nursing & Clinical Practices Volume 3 (2016), Article ID 3:IJNCP-174, 5 pages
http://dx.doi.org/10.15344/2394-4978/2016/174
Research Article
Gene Therapy for Peripheral Arterial Disease and Nursing Implications: Clinical Experience on the use of Sendai Viral Vector

Michiko Tanaka* and Yoshikazu Yonemitsu

R & D Laboratory for Innovative Biotherapeutics Science, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan
Dr. Michiko Tanakaa, R & D Laboratory for Innovative Biotherapeutics Science, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan; E-mail: tmiciko@med.kyushu-u.ac.jp
04 January 2016; 02 March 2016; 04 March 2016
Tanaka M, Yonemitsu Y (2016) Gene Therapy for Peripheral Arterial Disease and Nursing Implications: Clinical Experience on the use of Sendai Viral Vector. Int J Nurs Clin Pract 3: 174. doi: http://dx.doi.org/10.15344/2394-4978/2016/174
This study was supported by the Health and Labor Sciences Research Grant, and partially supported by the Japan Agency for Medical Research and development, AMED.

Abstract

Current trends in gene therapy affect nursing practice and research. As treatments with gene therapy progress, nurses are required to have advanced knowledge and techniques to provide nursing care for patients who undergo gene therapy. The challenges for nurses are adherence to ethical and regulatory guidelines, detailed knowledge of gene transfer and safety issues in the use of viral vectors, the ability to monitor unspecified symptoms, and the provision of non-standardized care for patients. In this article, the authors discussimplications for specialized nursing related to the use of virus vectors in gene therapy, with a focus on peripheral arterial disease.